Literature DB >> 8198906

Double-blind comparison of ondansetron, droperidol and saline in the prevention of postoperative nausea and vomiting.

T J Gan1, R Collis, M Hetreed.   

Abstract

We have compared the efficacy of ondansetron with droperidol and saline in the prevention of postoperative nausea and vomiting (PONV) in 120 ASA I and II patients undergoing hip and knee replacements and femoral resections. They received a standardized combined extradural and general anaesthetic and at the end of surgery were allocated randomly to receive droperidol 1.25 mg, ondansetron 4 mg or 0.9% saline in a 25-ml bag. An extradural mixture containing 0.5% plain bupivacaine 10 ml, fentanyl 500 micrograms and saline 30 ml was infused and PONV assessed for 24 h. Both ondansetron and droperidol were superior to saline in preventing vomiting (P < 0.01) although there was no significant difference between them. The incidence of vomiting was 17% for ondansetron, 18% for droperidol and 45% for saline. There was no significant difference in the incidence of nausea between the groups. Metoclopramide, the rescue antiemetric, was demanded by 38%, 34% and 17% of patients receiving saline, droperidol and ondansetron, respectively (ondansetron vs droperidol P < 0.05).

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8198906     DOI: 10.1093/bja/72.5.544

Source DB:  PubMed          Journal:  Br J Anaesth        ISSN: 0007-0912            Impact factor:   9.166


  9 in total

Review 1.  Risks and benefits of drugs used in the management of postoperative nausea and vomiting.

Authors:  Y F Sung
Journal:  Drug Saf       Date:  1996-03       Impact factor: 5.606

Review 2.  When placebo controlled trials are essential and equivalence trials are inadequate.

Authors:  M R Tramèr; D J Reynolds; R A Moore; H J McQuay
Journal:  BMJ       Date:  1998-09-26

3.  Antiemesis after total joint arthroplasty: does a single preoperative dose of aprepitant reduce nausea and vomiting?

Authors:  Timothy M DiIorio; Peter F Sharkey; Agnes M Hewitt; Javad Parvizi
Journal:  Clin Orthop Relat Res       Date:  2010-09       Impact factor: 4.176

4.  A korean predictive model for postoperative nausea and vomiting.

Authors:  Duck Hwan Choi; Justin Sang Ko; Hyun Joo Ahn; Jie Ae Kim
Journal:  J Korean Med Sci       Date:  2005-10       Impact factor: 2.153

5.  Prophylactic antiemetic therapy with ondansetron, tropisetron, granisetron and metoclopramide in patients undergoing laparoscopic cholecystectomy: a randomized, double-blind comparison with placebo.

Authors:  M Naguib; A K el Bakry; M H Khoshim; A B Channa; M el Gammal; K el Gammal; Y S Elhattab; M Attia; R Jaroudi; A Saddique
Journal:  Can J Anaesth       Date:  1996-03       Impact factor: 5.063

6.  Denial of effective treatment and poor quality of clinical information in placebo controlled trials of ondansetron for postoperative nausea and vomiting: a review of published trials.

Authors:  R L Aspinall; N W Goodman
Journal:  BMJ       Date:  1995-09-30

7.  Prevention of nausea and vomiting with ramosetron after total hip replacement.

Authors:  Yoshitaka Fujii; Hiroyoshi Tanaka
Journal:  Clin Drug Investig       Date:  2003       Impact factor: 2.859

8.  [Vomiting after gynecologic laparoscopy and under general anesthesia is associated with changes in excretion of serotonin metabolites].

Authors:  D Rüsch; C Strasser; I Celik; M Lengkong; H Wulf; J Scholz
Journal:  Anaesthesist       Date:  2004-03       Impact factor: 1.041

9.  Drugs for preventing postoperative nausea and vomiting in adults after general anaesthesia: a network meta-analysis.

Authors:  Stephanie Weibel; Gerta Rücker; Leopold Hj Eberhart; Nathan L Pace; Hannah M Hartl; Olivia L Jordan; Debora Mayer; Manuel Riemer; Maximilian S Schaefer; Diana Raj; Insa Backhaus; Antonia Helf; Tobias Schlesinger; Peter Kienbaum; Peter Kranke
Journal:  Cochrane Database Syst Rev       Date:  2020-10-19
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.